again. this is an interesting situation. first off, the assertion that the reason they paused the study was clinical trial supply would be medical mal practice for people in my business, clinical research. first you lock down your trial supply. that fails the sniff test. either they are incompetent at the university of oxford or lying. it s one or the other. worldwide supply of ivermectin is enormous. there is no way they would not have locked down their trial supply. i called up a good friend at the university of bats. she raised a series of points i would love to go over with you. laura: sure. her point is that this is